Diabetes and Kidneys:
Unraveling T2D's Silent Threat
Diabetes and Kidneys:
Unraveling T2D's Silent Threat
In this podcast series, recorded in the spring of 2024, we hear from a range of experts involved in the care of patients with CKD associated with T2D and explore how early diagnosis and management of CKD may slow progression of kidney disease and reduce cardiovascular events.
Meet the Experts
You are encouraged to report side effects or quality complaints of products to the FDA by visiting www.fda.gov/medwatch or calling 1-800-FDA-1088. For Bayer products, you can report these directly to Bayer by clicking here.
This site provides access to balanced and evidence-based medical information related to our therapeutic areas of focus and is intended to serve as a medical resource for US HCPs. This may include investigational compounds or investigational new uses of FDA-approved Bayer products. The information provided is not intended to be promotional or provide medical advice. Please refer to the full Prescribing Information for approved indications, contraindications, warnings and precautions, and adverse events.
